Low prices for HIV drugs are only one step forwardBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7435.349-d (Published 05 February 2004) Cite this as: BMJ 2004;328:349
- Peter A West, director (firstname.lastname@example.org)
- York Health Economics Consortium, University of York YO10 5NH
EDITOR—Anything that cuts the price of drugs for HIV treatment is potentially beneficial to people with HIV infection in the developing world, as, for example, the recent deal from the World Health Organization.1 But it remains only one step on a long path.
In many developing countries, …